Proposed rule 2026-23351
Rulemaking To Provide That N-acetyl-L-cysteine Is Not Excluded From the Dietary Supplement Definition
The Food and Drug Administration (FDA or we) is proposing to issue a regulation finding that N-acetyl-L-cysteine (NAC) is not excluded from the dietary supplement definition in the Federal Food, Drug, and Cosmetic Act (FD&C Act). This action, if finalized, would allow products containing NAC to be lawfully marketed as dietary supplements, provided that such products are not otherwise in violation of the FD&C Act. We also propose to provide that the addition of NAC to a dietary supplement is not a prohibited act under section 301(ll) of the FD&C Act.
Source-supplied record
Document details
- Document number
- 2026-23351
- Published
- Nov 17, 2026
- Effective
- Not supplied
- Comments close
- Jan 19, 2027 (open)
- Federal Register citation
- 91 FR 73717
Docket identifiers
- Docket No. FDA-2025-N-2699
CFR references
- Title 21, part 190